Peasgood T, Bailey C, Chen G, De Silva A, De Silva Perera U, Norman R
PLoS One. 2024; 19(6):e0302886.
PMID: 38829857
PMC: 11146702.
DOI: 10.1371/journal.pone.0302886.
Lakdawalla D, Doctor J
Eur J Health Econ. 2024; 25(8):1393-1416.
PMID: 38411845
PMC: 11639167.
DOI: 10.1007/s10198-023-01659-7.
Bahmanziari N, Mohammadi S, Takian A, Arab M, Harirchi I
J Med Ethics Hist Med. 2022; 14:23.
PMID: 35600216
PMC: 9076495.
DOI: 10.18502/jmehm.v14i23.8183.
Lakdawalla D, Phelps C
Eur J Health Econ. 2021; 23(3):433-451.
PMID: 34495445
PMC: 8964662.
DOI: 10.1007/s10198-021-01367-0.
Neumann P, Ollendorf D, Cohen J
Health Serv Res. 2021; 56(6):1093-1099.
PMID: 34085289
PMC: 8586482.
DOI: 10.1111/1475-6773.13686.
US Clinicians' Experiences and Perspectives on Resource Limitation and Patient Care During the COVID-19 Pandemic.
Butler C, Wong S, Wightman A, OHare A
JAMA Netw Open. 2020; 3(11):e2027315.
PMID: 33156349
PMC: 7648254.
DOI: 10.1001/jamanetworkopen.2020.27315.
Health technology assessment with risk aversion in health.
Lakdawalla D, Phelps C
J Health Econ. 2020; 72:102346.
PMID: 32592923
PMC: 7402585.
DOI: 10.1016/j.jhealeco.2020.102346.
Does moral reasoning influence public values for health care priority setting?: A population-based randomized stated preference survey.
Denburg A, Ungar W, Chen S, Hurley J, Abelson J
Health Policy. 2020; 124(6):647-658.
PMID: 32405121
PMC: 7219374.
DOI: 10.1016/j.healthpol.2020.04.007.
Public engagement in setting healthcare priorities: a ranking exercise in Cyprus.
Farmakas A, Theodorou M, Galanis P, Karayiannis G, Ghobrial S, Polyzos N
Cost Eff Resour Alloc. 2017; 15:16.
PMID: 28808427
PMC: 5551077.
DOI: 10.1186/s12962-017-0078-3.
The prioritization preferences of pan-Canadian Oncology Drug Review members and the Canadian public: a stated-preferences comparison.
Skedgel C
Curr Oncol. 2016; 23(5):322-328.
PMID: 27803596
PMC: 5081008.
DOI: 10.3747/co.23.3033.
Who Shall Not Be Treated: Public Attitudes on Setting Health Care Priorities by Person-Based Criteria in 28 Nations.
Rogge J, Kittel B
PLoS One. 2016; 11(6):e0157018.
PMID: 27280775
PMC: 4900563.
DOI: 10.1371/journal.pone.0157018.
Prioritising health service innovation investments using public preferences: a discrete choice experiment.
Erdem S, Thompson C
BMC Health Serv Res. 2014; 14:360.
PMID: 25167926
PMC: 4166469.
DOI: 10.1186/1472-6963-14-360.
Why equal treatment is not always equitable: the impact of existing ethnic health inequalities in cost-effectiveness modeling.
McLeod M, Blakely T, Kvizhinadze G, Harris R
Popul Health Metr. 2014; 12:15.
PMID: 24910540
PMC: 4047777.
DOI: 10.1186/1478-7954-12-15.
A person trade-off study to estimate age-related weights for health gains in economic evaluation.
Petrou S, Kandala N, Robinson A, Baker R
Pharmacoeconomics. 2013; 31(10):893-907.
PMID: 23990389
DOI: 10.1007/s40273-013-0085-y.
Societal preferences for standard health insurance coverage in the Netherlands: a cross-sectional study.
van der Wulp I, van den Hout W, de Vries M, Stiggelbout A, van den Akker-van Marle E
BMJ Open. 2012; 2(2):e001021.
PMID: 22492390
PMC: 3323810.
DOI: 10.1136/bmjopen-2012-001021.
The relevance of personal characteristics in allocating health care resources-controversial preferences of laypersons with different educational backgrounds.
Winkelhage J, Diederich A
Int J Environ Res Public Health. 2012; 9(1):223-43.
PMID: 22470289
PMC: 3315072.
DOI: 10.3390/ijerph9010223.
Age as a criterion for setting priorities in health care? A survey of the German public view.
Diederich A, Winkelhage J, Wirsik N
PLoS One. 2011; 6(8):e23930.
PMID: 21904600
PMC: 3164130.
DOI: 10.1371/journal.pone.0023930.
The cost-effectiveness of cash versus lottery incentives for a web-based, stated-preference community survey.
Gajic A, Cameron D, Hurley J
Eur J Health Econ. 2011; 13(6):789-99.
PMID: 21691841
DOI: 10.1007/s10198-011-0332-0.
The social value of a QALY: raising the bar or barring the raise?.
Donaldson C, Baker R, Mason H, Jones-Lee M, Lancsar E, Wildman J
BMC Health Serv Res. 2011; 11:8.
PMID: 21223540
PMC: 3023672.
DOI: 10.1186/1472-6963-11-8.
Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67.
Desser A, Gyrd-Hansen D, Olsen J, Grepperud S, Kristiansen I
BMJ. 2010; 341:c4715.
PMID: 20861122
PMC: 2944922.
DOI: 10.1136/bmj.c4715.